1454 results about "Ethyl phosphate" patented technology

Composition for pharmaceutical or cosmetic use, capable of forming a microemulsion, comprising at least: an active principle, a lipophilic phase consisting of a mixture of fatty acid esters and glycerides, a surfactant (SA), a cosurfactant (CoSA), a hydrophilic phase, characterized: in that the lipophilic phase consists of a mixture of C8 to C18 polyglycolized glycerides having a hydrophilic-lipophilic balance (HLB) of less than 16, this lipophilic phase representing from 30 to 75% of the total weight of the composition; in that the surfactant (SA) is chosen from the group comprising saturated C8-C10 olyglycolized glycerides and oleic esters of polyglycerol, this surfactant having an HLB of less than 16; in that the cosurfactant (CoSA) is chosen from the group comprising lauric esters of propylene glycol, oleic esters of polyglycerol and ethyl diglycol; in that the SA/CoSA ratio is between 0.5 and 6; and in that the hydrophilic phase of the final microemulsion is supplied after ingestion by the physiological fluid of the digestive milieu.

The present invention relates to large scale preparation of LNA phosphoramidites using a 2-cyanoethyl-N,N,N′,N′-tetra-substituted phosphoramidite and a nucleophilic activator, e.g. 2-cyanoethyl-N,N,N′,N′-tetraisopropylphosphoramidite and 4,5-dicyanoimidazole. The method is faster and more cost efficient that previously known methods.

There are disclosed a method for removing CO2 from a combustion exhaust gas which comprises the step of bringing the combustion exhaust gas under atmospheric pressure into contact with an aqueous solution of a hindered amine selected from the group consisting of 2-amino-2-methyl-1-propanol, 2-methylaminoethanol, 2-ethylaminoethanol and 2-piperidineethanol; and another method for removing carbon dioxide from a combustion exhaust gas which comprises the step of bringing the combustion exhaust gas under atmospheric pressure into contact with a mixed aqueous solution of 100 parts by weight of an amine compound (X) selected from the group consisting of 2-amino-2-methyl-1,3-propanediol, 2-amino-2-methyl-1-propanol, 2-amino-2-ethyl-1,3-propanediol, t-butyldiethanolamine and 2-amino-2-hydroxymethyl-1,3-propanediol; and 1-25 parts by weight of an amine compound (Y) selected from the group consisting of piperazine, piperidine, morpholine, glycine, 2-methylaminoethanol, 2-piperidineethanol and 2-ethylaminoethanol.

Cosmetic compositions containing a micronized metal oxide along with a 4-substituted resorcinol derivatives of the general formula I exhibit improved storage stability:

• • where each R₁ and R₂, independently, represents a hydrogen atom, —CO—R (acyl group), —COO—R, CONHR; where R represents saturated or unsaturated, linear, branched or cyclic C₁-C₁₈ hydrocarbon groups; and
  • R₃ represents (1) an alkyl group, having from 1 to 18 carbon atoms, preferably having from 2 to 12 carbon atoms, with or without substitution of one or more hydrogen atoms of a linear alkyl group with a methyl or ethyl group; e.g., R₃ constitutes linear or branched chain alkyls, or (2) a group of the general formula formula (II)
  • Where X is preferably H, n is 0 to 3 and the dashed lines represents an optional double bond.

Use is made, for selectively hydrogenating the olefinic double bonds of block copolymers, at least one block of which comprises olefinic double bonds, using a catalyst based on a metal from Group VIII in a medium comprising an organic solvent for the copolymer and an ionic liquid as solvent for the catalyst, of a water-immiscible ionic liquid, preferably an ionic liquid for which the anion is the hexafluorophosphate anion and the cation is the 1-butyl-3-methylimidazolium (bmim⁺) or 1-ethyl-3-methylimidazolium (emim⁺) cation.

Applied to poly(styrene)-b-poly(butadiene)-b-poly(methyl methacrylate) block copolymers, the poly(butadiene) block of which predominantly possesses a 1,4-microstructure, this process results in copolymers for which the degree of hydrogenation is at least equal to 50% and which exhibit a melting point of greater than 30 °C.

The invention provides a preparation method of brivaracetam. The preparation method of brivaracetam comprises the following steps of in an alkaline reagent, reacting malonate ester and (R)-epichlorohydrin to obtain lactone (II), reacting the lactone (II) and an ethyl metal-based reagent to obtain an intermediate (III), removing carboxylase to obtain (R)-4-propyl-dihydrofuran-2-ketone (IV), performing ring-opening reaction under the action of a halogenated ring-opening reagent to obtain (R)-3-halogenarated methyl hexanoate or (R)-3- halogenarated methyl hexyl acetate (V), and reacting with (S)-2-aminobutanamide or an acceptable salt, so as to obtain the brivaracetam. The preparation method has the advantages that the high-purity brivaracetam (HPLC (high performance liquid chromatography: greater than 96%) and stereo rotary brivaracetam (chirality HPLC: greater than 98%) can be directly prepared; the silicagel column separation and purification or the chirality preparation column separation and purification is not used, so that the complicated separation and purification step is not performed, the cost is saved, and the preparation method is more suitable for industrial production.

The invention relates to a functional fiber and its manufacturing method, where the functional fiber has a skin-core structure, the weight ratio of skin to core 3/7 - 7/3; and the formula of the skin materials in weight percent comprises: skin polymer 91.6-97.6%, far infrared powder 2-8%, and coupling agent 0.1-0.4%; the skin polymer is one of PTT, PBT, PA-6, PET and PP with fusion index of 25-50; the coupling agent is one of gama-shink glycerol oxy propyl trimethoxy silane, gama-methyl propylene acyl oxy trimethoxy silane, N-beta-(amido ethyl)-gama amido propyl trimethoxy silane, and gama-amido propyl triethoxy silane; and the formula of the core-layer materials in weight percent comprises: core-layer polymer 88-99%, and flavor 1-12%; wherein the core-layer polymer is one of PE, PP and PET with melting point of 150-200 deg.C. The fiber of the invention has far infrared emissivity of 81-86%, very strong spicery and is a synthetic health functional fiber.

The invention belongs to the field of medicine, and in particular relates to a medical application of 2-([1,1'-biphenyl]-4-yl)-2-oxoethyl 4-((3-chloro-4-methylphenyl) amino)-4-oxobutanoate in a selective histone lysine-specific demethylase 1 (LSD1) inhibitor, especially the application in anti-tumor medicaments. Pharmacodynamic tests indicate that the 2-([1,1'-biphenyl]-4-yl)-2-oxoethyl 4-((3-chloro-4-methylphenyl) amino)-4-oxobutanoate has a remarkable LSD1 inhibiting effect, and has selectivity to homologous proteins MAO-A (monoamine oxidase-A) and MAO-B.

Cosmetic compositions containing organic sunscreens along with a 4-substituted resorcinol derivatives of general formula I exhibit improved storage stability and oxidative stability:

where each R₁ and R₂, independently, represents a hydrogen atom, —CO—R (acyl group), —COO—R CONHR; where R represents saturated or unsaturated, linear, branched or cyclic C₁-C₁₈ hydrocarbon groups; and

R₃ represents (1) an alkyl group, having from 1 to 18 carbon atoms, preferably having from 2 to 12 carbon atoms, with or without substitution of one or more hydrogen atoms of a linear alkyl group with a methyl or ethyl group; e.g., R₃ constitutes linear or branched chain alkyls, or (2) a group of the general formula formula (II)

Where X is preferably H, n is 0 to 3 and the dashed lines represents an optional double bond.

The invention relates to administration of an anti-CTLA4 antibody, particularly human antibodies to human CTLA4, such as those having amino acid sequences of antibodies 3.1.1, 4.1.1, 4.8.1, 4.10.2, 4.13.1, 4.14.3, 6.1.1, ticilimumab (also referred to as 11.2.1 or CP-675,206), 11.6.1, 11.7.1, 12.3.1.1, 12.9.1.1, and ipilimumab (also referred to as 10D1 or MDX-010), in combination with an indolinone receptor tyrosine kinase inhibitor (RTKI), e.g., N-[2-diethylamino]ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (compound 1), N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (compound 2), and 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (compound 3), for treatment of cancer. The invention relates to administering a combination of an anti-CTLA4 antibody and an indolinone RTKI such as, inter alia, compound 1. The invention relates to neoadjuvant, adjuvant, first-line, second-line, and third-line therapy of cancer, whether localized or metastasized, and at any point(s) along the disease continuum (e.g., at any stage of the cancer).

Disclosed is a herbicidal mixture comprising (a) at least one herbicide compound selected from the pyrimidines of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof:

wherein

• • R¹ is cyclopropyl, 4-Br-phenyl or 4-Cl-phenyl;
  • X is Cl or Br;
  • R² is H, C₁-C₁₄ alkyl, C₂-C₁₄ alkoxyalkyl, C₃-C₁₄ alkoxyalkoxyalkyl, C₂-C₁₄ hydroxyalkyl or benzyl; and
  • (b) at least one additional herbicide or herbicide safener compound selected from the group consisting of (b1) ACCase inhibitors, (b2) AHAS inhibitors, (b3) photosystem II inhibitors, (b4) photosystem I electron diverters, (b5) PPO inhibitors, (b6) EPSP synthase inhibitors, (b7) GS inhibitors, (b8) VLCFA inhibitors, (b9) auxin mimics, (b10) auxin transport inhibitors, (b11) other herbicides selected from the group consisting of flamprop-M-methyl, flamprop-M-isopropyl, difenzoquat, DSMA, MSMA, bromobutide, flurenol, cinmethylin, cumyluron, dazomet, dymron, methyldymron, etobenzanid, fosamine-ammonium, isoxaflutole, asulam, clomazone, mesotrione, metam, oxaziclomefone, oleic acid, pelargonic acid and pyributicarb, (b12) herbicide safeners selected from the group consisting of benoxacor, 1-bromo-4-[(chloromethyl)sulfonyl]benzene, cloquintocet-mexyl, cyometrinil, dichlormid, 2-(dichloromethyl)-2-methyl-1,3-dioxolane, fenchlorazole-ethyl, fenclorim, flurazole, fluxofenim, furilazole, isoxadifen-ethyl, mefenpyr-diethyl, methoxyphenone, naphthalic anhydride and oxabetrinil, and their salts. Also disclosed is a method for controlling the growth of undesired vegetation comprising contacting the vegetation or its environment with a herbicidally effective amount of a mixture of the invention (e.g., as a composition described herein).

The present invention is a formable dental treatment tray utilizing poly(2-ethyl-2-oxazoline) and a gelatinous active. Blending of the active is accomplished by mixing the Poly(2-ethyl-2-oxazoline) with an active ingredient, such as a peroxide like hydrogen peroxide, carbamide peroxide, sodium perborate, or sodium percarbonate, usually also with water or an appropriate organic solvent. Peroxide concentrations in these new gels can reach a 30% concentration of hydrogen peroxide while maintaining a shelf life of six months at room temperature without developing peroxide decomposition. The gels are applied to an appropriate backing and dried to a gelatinous state. In use, the active is hydrated and regains adhesiveness. Then the tray is pressed and formed around a user's dental arch to form the customizable tray. Multiple active ingredients may be used, with or without peroxide, for accomplishing desired treatment regimens.

Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis(ethylene)phosphoramidate, andmethods of treating cancer comprising administering such compounds.

A crystal form of folic acid antagonistic N-(4-(2-(2-amino-4,7-methyl-4-oxo-1H-pyrrolo(2,3-d)pyrimidine-5-radical)ethyl)benzoyl)-L-glutamic acid disodium salt and its production are disclosed.

The present invention relates to the preparation of Timisatan as one active component for antihypertensive medicine. The carboxylic ester derivative is first obtained through the nucleophilic substitution reaction between some intermediate and 4'-bromomethyl biphenyly-2-carboxylic ester, and then hydrolyzed to eliminnate protection radical and to obtain the destination product. In the technological process of the present invention, methyl radical and ethyl radical are used as protecting radical, and this facilitates and stabilizes the preparation of 4'-bromomethyl biphenylyl-2-methyl carboxylic ester and 4'-bromomethyl biphenylyl-2-ethyl carboxylic ester, and results in easy to control reaction with the intermediate, less impurity, easy elimination of protecting radical and high product yield and quality.

This invention is drawn to a process for producing and recovering one or more high-purity xylene isomers from a feed stream having a substantial content of C₉ and heavier hydrocarbons. The feed stream is processed to de-ethylate heavy aromatics, fractionated and passed to a circuit comprising C₈-aromatic isomer recovery and isomerization to recover the high-purity xylene isomer with lowered energy costs.

The invention discloses a synthesis method of a pharmaceutical intermediate of tertiary butyl-(2-(biphenyl-4-yl)-1-(methylol) ethyl) carbamate, which comprises the steps that: diethyl acetamidornalonate and 4-substituent biphenyl are taken as initial raw materials and undergone six steps of reactions including condensation, decarboxylation, hydrolysis, reduction and acylation to obtain the tertiary butyl-(2-(biphenyl-4-yl)-1-(methylol) ethyl) carbamate. The method of the invention has the advantages of available raw materials, convenient operation, high reaction yield rate, recoverable solvents used in the synthesis course, thereby reducing environmental pollution and greatly reducing production cost; according to test results, the products obtained by the method has reliable quality and stable performance.

The invention provides a preparation method for (I) 2- amido -2-[2-(4- alkyl phenyl)ethyl]-1ú¼3- propanediol, which comprises: using alkyl benzene (II) as initial material, with Lewis acid existing, to take Friedel-Crafts acylating reaction with 3- halogenated propionyl chloride and generate beta- halogenated alkylpropiophenone (IV); reducing IV by hydride to obtain 3- nitro -1-(4- alkyl phenyl) propanol (V); preparing 2- nitro -2- methylol -4-(4- alkyl phenyl)-1ú¼4butanediol (VI) by hydroxymethylation; reducing nitro and removing benzalcoholhydroxy to VI and obtaining the objective product.

The invention belongs to the technical field of nano-silver antibacterial materials and discloses an aminated polyethylene glycol functional graphene oxide loaded nano-silver antibacterial material, a preparation method of the antibacterial material and an application of the antibacterial material in the fields of bacteriostasis and sterilization. The method comprises the following steps: adding aminated polyethylene glycol into an aqueous solution of graphene oxide, adding 1-ethyl-(3-dimethylaminopropyl) carbonyldiimine hydrochloride and N-hydroxy succinimide, regulating the pH value, stirring, and reacting, thereby obtaining the aminated polyethylene glycol modified graphene oxide; preparing the aqueous solution of the graphene oxide, adding silver nitrate, heating until the solution is boiled after dissolving, adding sodium citrate or NaBH4 aqueous solution, reacting, and cooling, thereby obtaining the aminated polyethylene glycol functional graphene oxide loaded nano-silver antibacterial material. The antibacterial material prepared by the invention has good water solubility and stability, the loading efficiency and antibacterial activity are obviously improved, and the antibacterial material has obvious antibacterial activity and can be widely applied to the fields of bacteriostasis and sterilization.

The invention belongs to the technical field of preparation of a regenerated cellulose material and discloses a preparation method of the regenerated cellulose material. A employed solvent is a carboxylic acid type ionic liquid or is a co-solvent which is composed of the carboxylic acid type ionic liquid and an active-proton-free polar organic solvent, wherein the carboxylic acid type ionic liquid is preferably selected from 1-ethyl-3-methylimidazole acetate, 1-propyl-3-methylimidazole acetate or 1-butyl-3- methylimidazole acetate; an auxiliary solvent is selected from one or more of DMF, DMAc, DMI, DMSO, pyrrodine, acetone, dichloromethane and dichloroethane; and a solidifying agent is preferably selected from alcohol organic solvents. The carboxylic acid type ionic liquid is most preferably selected from the 1-ethyl-3-methylimidazole acetate and the 1-butyl-3-methylimidazole acetate; the auxiliary solvent is most preferably DMF; and the solidifying agent is preferably ethanol; wherein a mass ration of the carboxylic acid type ionic liquid to the auxiliary solvent is 5:5. By means of the preparation method, mechanical performances of a regenerated cellulose product can be significantly improved and environmental pollution can be reduced.

This invention relates to antistatic biaxially oriented polypropylene (BOPP) combination, using polypropylene as material and including opening agent, smoothness agent, antistatic agent, antioxidant, processing and heat stabilizer, wherein the antistatic agent is glycerin fatty acid ester or two ester, polyethylene glycol ester, amides and/or ethyl amines, the anti-adhesion agent is a series of silicon dioxide inorganic matters or crosslinked polysiloxane particles, the opening agent is the synthesized silicon dioxide or silicates, calcium stearate, the smoothness agent is oleic acid amide, erucic acid amide and/or silicone, and the primary and secondary antioxidants are phosphite stabilizing agent and hindered amine antioxidant. The preparation method includes adding antistatic agent, etc. additives in granulation part, and adding them into PP, mixing, and melting and granulating to obtain the BOPP antistatic resin, or pre-preparing antistatic anti-adhesion smoothness masterbatch by various components. This invention keeps the original performances of BOPP with a lower volume of auxiliaries, and obtain good performances of antistatic property, anti-adhesion, and smoothness.

Clear, high load water miscible emulsions of quinoxalinyl ester herbicides, particularly quizalofop-p-ethyl, as a single phase, translocatable composition which is free of xylene and alkylphenol ethoxylate surfactants and concentrate matrix for the active quinoxalinyl ester component at between about 9 and about 25 wt. % active concentration.

The invention discloses an extraction seperation method of a rare-earth element. According to extraction seperation method, positive ions and negative ions in a quaternary ammonium salt ionic liquid extracting agent, i.e. 2-ethylhexyl phosphonic acid mono 2-ethylhexyl ester trialkyl methyl ammonium and phosphonic acid binary (2-ethylhexyl) ester trialkyl methyl ammonium react with rare earth ions to form neutral complex molecules, and the positive ions and negative ions in the quaternary ammonium salt ionic liquid extracting agent have inner synergistic effect and competitive effect in the process of extracting the rare-earth element, thereby the seperation factor of the rare-earth element is increased. Therefore, the extraction seperation method provided by the invention has the advantages that an interfacial phenomenon is good in the extraction process, no emulsification is generated, and an extracting solvent does not need to be saponified, the extraction seperation method has higher seperation factor of the rare-earth element and particularly high extraction seperation effect on heavy rare earth. In addition, the extraction seperation method of the rare-earth element, which is provided by the invention, has low extraction acidity and back extraction acidity and consumes little acid.

The invention discloses a preparation method of a polyamide composite nanofiltration membrane, which comprises the following steps of partially hydrolyzing a polyacrylonitrile-based membrane under alkaline and heat treatment conditions, and activating the membrane in 1-ethyl-(3-dimethyl amino propyl) carbonyl diimine hydrochloride ethylene dichloride-hydrogen chloride (EDC-HCl) and N-hydroxyl succinimide (NHS); and then sequentially immersing the membrane in water phase monomer piperazine with low concentration and organic phase monomer benzenetricarbonyl trichloride, and the polyamide composite nanofiltration membrane is prepared by interfacial polymerization. The preparation method of the polyamide composite nanofiltration membrane has the advantages that compared with a traditional method, the method utilizes monomer solution with low concentration to perform the interfacial polymerization, high permeation flux can be obtained under ultra-low pressure (0.1MPa), and filter dye solution and saline solution have high separation selectivity.

Cosmetic and/or pharmaceutical preparations comprising (a) a dialkyl carbonate of the formula (I): wherein R<1 >is a linear alkyl and/or alkenyl group having from 6 to 22 carbon atoms, a 2-ethylhexyl, isotridecyl or isostearyl group or a group derived from a polyol having from 2 to 15 carbon atoms and at least two hydroxyl groups; R<2 >has the same meaning as R<1 >or is an alkyl group having from 1 to 5 carbon atoms and (b) a propellant can be used as aerosols.

The invention relates to a method for separating zinc, fluorine and chlorine from fluorine- and chlorine-containing zinc sulfate solution, in particular to a method for separating zinc, fluorine and chlorine from fluorine- and chlorine-containing secondary zinc resource Sulfuric acid leaching solution. In the method, during solution pretreatment, zinc powder and calcium oxide are added into the fluorine- and chlorine-containing zinc sulfate solution; during extraction, di-(2-ethylhexyl)phosphate is adopted as an extracting agent and kerosene is adopted as a diluent to prepare an organic phase with certain concentration, the organic phase is mixed with the pretreated solution for extraction, zinc in a water phase is transferred into the organic phase, fluoride ions and chloride ions are remained in the water phase, and the separation of the zinc, fluorine and chlorine is realized; and during back extraction, sulfuric acid solution serves as a back washing agent, the zinc-containing loaded organic phase is mixed for back extraction, the zinc in the loaded organic phase is transferred into the water phase again, zinc sulfate solution is obtained and the organic phase is subjected to impurity removal and recycled. The zinc, fluorine and chlorine separation efficiency is over 95 percent, and the obtained zinc sulfate solution has high purity and can be combined into a purification flow of the traditional zinc smelting. The method has the advantages that: the cost is low, the method is easy to operate, the efficiency is high, and the continuous production can be realized.

The invention discloses an amphiphilic prodrug of 7- ethyl-10-hydroxycamptothecin, which is prepared by connecting hydroxyl at the site 10 and/or 20 site of the 7-ethyl-10- hydroxycamptothecin and a hydrophilic group through a scissionable chemical bond. The amphiphilic prodrug is self-assembled in water to form a micelle or vesicle structure. Therefore, on one hand, the solubility of SN-38 in water is greatly increased, and the stability of SN-38 lactone rings is improved; and on the other hand, the drug loading rate is high and the SN-38 can be quickly released in cells, consequently the defect of low drug loading rate of traditional drugs is overcame. Moreover, with the nano-micelles or the nano-vesicles of the prodrug, EPR (enhanced permeability and retention) effect targeted cancer tissues of tumors can be effectively utilized.

Hard surface cleaning compositions comprise: A. Surfactant, e.g., a nonionic ethoxylated alcohol; B. Solvent, e.g., propyleneglycol n-butyl ether; C. Low VOC, low odor, alkanolamine selected from the group consisting of tris(hydroxymethyl)amino methane; 2-amino-2-methyl-1,3-propanediol; 2-amino-2-ethyl-1,3-propanediol; 2-amino-2-methyl-1-propanol; N,N-dimethylamino-2-methyl-1-propanol; and 3-amino-4-octanol; D. Water, and E. Optionally, one or more of an alkaline agent, builder, fragrance, preservative, biocide, colorant, dye and rheology modifier.

The invention relates to a kind of chiral diphosphite ligands, an iridium composite catalyst thereof, a preparation method and application thereof. The ligands are obtained through using chiral (R)-(S)-1-dimethylamino ethyiferroene as raw materials to react with diphenyl phosphonium chloride under the effect of butyl lithium and then to carry out displacement reaction with diaryl phosphine alkane. The chiral diphosphite ligands respectively act with homotropilidene compositions of iridous chloride, tetrabutyl ammonium iodide and glacial acetic acid, and imine asymmetrical hydrogenization catalysts can be obtained. When the iridium-diphosphine catalysts are used for catalyzing 2-methyl-6-ethyl-N-methylene aniline (EMA-imine) hydrogenization reaction, (S)-N-(1-anisyl-2-propyl)-2-methyl-6- ethylaniline ((S)-NNA) can be obtained, and the antimer excessive value (ee) can reach 86.5 percent. The (S)-NNA and chloracetyl chloride carry out acylation reaction to obtain (S)-metolachlor with the ee value of 86 percent. Thereby, the ligands provided by the invneiton can be used for synthesizing chiral herbicidal chemicals of (S)-metolachlor.

The invention provides a method for extracting lithium from salt lake brine. The method comprises the following steps: 1) preparing extract organic phases which comprise a composite extracting agent and a diluent, wherein the composite extracting agent is prepared by mixing tributyl phosphate with N,N-bis(2-ethylhexyl)-3-butanone acetamide according to a volume percent ratio of 50% to 50%; the diluent is sulfonated kerosene; 2) preparing an extract water phase which is an LiCl-MgCl2-H2O system; 3) adding HCl and FeCl3.6H2O to the extract water phase, wherein the ratio of amount of substances of iron and lithium is controlled to be 1.3 to 1, the acid concentration is 0.5mol/L, and the lithium concentration is 1-3g/L; 4) standing after fully mixing the extract water phase obtained in the step 3) with the extract organic phases obtained in the step 1) in a volume ratio of 1 to 2, and then separating a liquid phase. By adopting the method, the problems that the corrosivity of high-concentration tributyl phosphate towards extraction equipment is stronger and the dissolution loss of the extracting agent in water is serious in long-term operation are solved, and the lithium extraction efficiency of the prior art is achieved. The extraction method is simple and reliable to operate.